Within the Inter-Territorial Council of the National Health System and wants to express the deep distress of professional group against this new aggression threatens the financial viability of many pharmacies in Spain.

The Cofman asked why the General Council of Pharmacists (CGCF), if they materialize these measures, decisive action - without excluding any, in protest of further cuts in addition to the 16 measures applied since 2000 to the pharmacy and that have made this area the main pagan insufficient budget allocation for health.

Far from ensuring the sustainability of the public, government forces again to laboratories, distributors and pharmacies to fund health as a whole, when many pharmacies and small businesses are on the verge of bankruptcy. This is inconceivable, especially if one considers the enormous debt carried by the NHS with its suppliers and the unpaid bill of recipes that are suffering Spanish pharmacies since last May, which could be generalized from September in Spain and could cause shortages of medicines.

The main solution provided by the Government to save on medications through prescription by active principle (PPP) has not shown significantly more efficient than the current policy prescription that follows in the Autonomous Community of Madrid and is a source of ongoing conflict in doctors and pharmacies to impose this measure by law, opening a breach in the relationship of trust between health professionals and patients.

From a health point of view, the PPA will be a greater effort of all professionals, in order to avoid adherence to treatment is a barrier for patients, especially those with polypharmacy.

Another measure is a clear economic loss for the industry without contributing to the sustainability of the NHS is cutting 15 percent of the prices of medicines that carry more than ten years in the market and do not have a generic because the manufacturers have not found sufficient commercial incentive in many cases. This new price reduction, in addition to that applied in 2010, affects 33% percent of the total market. This is a policy doomed exhausted that many brands have already adjusted rates, causing a shift in prescribing to more expensive treatments.

Health authorities are also promoting the custom systems drug dosage without explaining its scope and without regard to this dispensation requires greater availability of time and resources by pharmacists. The Cofman is willing to work in this policy provided that appropriate rewards their performance.

Finally, the Government has promised a plan of aid to pharmacies located in towns of less than 1,500 inhabitants without specifying its contents, regardless of neighborhood pharmacies there are equally committed to their viability as any other pharmacies that the government announces .

The Ministry of Health has acted once again on the fly, perhaps motivated by the pressure of the Autonomous Communities, confusing saving measures, not rigorously quantified, the viability of companies. In any case, we opt for a rational and efficient management throughout the NHS, without pushing the system only to providers who are not able to maintain or has been exerting pressure on prices, resulting in less margin, or the quality of the service today are the beneficiaries of the NHS.